JP2023543433A5 - - Google Patents
Info
- Publication number
- JP2023543433A5 JP2023543433A5 JP2023518280A JP2023518280A JP2023543433A5 JP 2023543433 A5 JP2023543433 A5 JP 2023543433A5 JP 2023518280 A JP2023518280 A JP 2023518280A JP 2023518280 A JP2023518280 A JP 2023518280A JP 2023543433 A5 JP2023543433 A5 JP 2023543433A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridine
- pyrimidine
- fluoro
- amine
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063081126P | 2020-09-21 | 2020-09-21 | |
| US63/081,126 | 2020-09-21 | ||
| US202163221959P | 2021-07-15 | 2021-07-15 | |
| US63/221,959 | 2021-07-15 | ||
| PCT/US2021/051226 WO2022061273A1 (en) | 2020-09-21 | 2021-09-21 | Cdk inhibitors and their use as pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543433A JP2023543433A (ja) | 2023-10-16 |
| JP2023543433A5 true JP2023543433A5 (https=) | 2025-01-16 |
Family
ID=78087595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518280A Pending JP2023543433A (ja) | 2020-09-21 | 2021-09-21 | Ｃｄｋ阻害剤及び医薬としてのその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11685744B2 (https=) |
| EP (1) | EP4214213A1 (https=) |
| JP (1) | JP2023543433A (https=) |
| KR (1) | KR20230123919A (https=) |
| CN (1) | CN116583283B (https=) |
| AU (1) | AU2021345423A1 (https=) |
| CA (1) | CA3196016A1 (https=) |
| IL (1) | IL301509B1 (https=) |
| MX (1) | MX2023003264A (https=) |
| WO (1) | WO2022061273A1 (https=) |
| ZA (1) | ZA202304541B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220079851A (ko) * | 2019-09-11 | 2022-06-14 | 프렐루드 테라퓨틱스, 인코포레이티드 | Cdk 억제제 및 약제로서의 이의 용도 |
| EP4433059A4 (en) * | 2021-11-15 | 2025-06-18 | Erasca, Inc. | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE |
| US20250109140A1 (en) * | 2022-01-05 | 2025-04-03 | Remix Theraputics Inc. | 5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases |
| CA3245813A1 (en) * | 2022-03-23 | 2023-09-28 | Prelude Therapeutics, Incorporated | POLYMORPHIC COMPOUNDS AND THEIR USES |
| TW202400168A (zh) * | 2022-05-04 | 2024-01-01 | 美商艾瑞斯卡公司 | 噻吩ulk1/2抑制劑及其用途 |
| WO2024051717A1 (zh) * | 2022-09-08 | 2024-03-14 | 上海深势唯思科技有限责任公司 | 作为plk1抑制剂的化合物及其制备方法和用途 |
| WO2025128616A1 (en) * | 2023-12-12 | 2025-06-19 | Genesis Therapeutics, Inc. | Compounds for treating cancer |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
| US5350395A (en) | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US5061273A (en) | 1989-06-01 | 1991-10-29 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US4748982A (en) | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
| US5674278A (en) | 1989-08-24 | 1997-10-07 | Arterial Vascular Engineering, Inc. | Endovascular support device |
| US6344053B1 (en) | 1993-12-22 | 2002-02-05 | Medtronic Ave, Inc. | Endovascular support device and method |
| US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
| JP2007501827A (ja) * | 2003-08-08 | 2007-02-01 | ファルマシア・イタリア・エス・ピー・エー | キナーゼ阻害剤として活性なピリミジルピロール誘導体 |
| EP2205242B1 (en) | 2007-09-12 | 2015-04-15 | Genentech, Inc. | Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| WO2009040399A1 (en) * | 2007-09-28 | 2009-04-02 | Nerviano Medical Sciences S.R.L. | Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| WO2009046416A1 (en) | 2007-10-05 | 2009-04-09 | Targegen Inc. | Anilinopyrimidines as jak kinase inhibitors |
| CA2908098A1 (en) | 2013-03-15 | 2014-09-25 | Celgene Avilomics Research, Inc. | Mk2 inhibitors and uses thereof |
| CN106810536A (zh) * | 2015-11-30 | 2017-06-09 | 甘李药业股份有限公司 | 一种蛋白激酶抑制剂及其制备方法和医药用途 |
| CN108779117B (zh) * | 2015-12-27 | 2021-08-31 | 重庆复创医药研究有限公司 | 一类激酶抑制剂 |
| WO2017133701A1 (en) * | 2016-02-06 | 2017-08-10 | Shanghai Fochon Pharmaceutical Co., Ltd. | Certain protein kinase inhibitors |
| EP3939986A1 (en) | 2017-08-09 | 2022-01-19 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| US10711007B2 (en) | 2018-03-14 | 2020-07-14 | Prelude Therapeutics Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
| US12133841B2 (en) | 2018-05-22 | 2024-11-05 | Js Innomed Holdings Ltd. | Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof |
| CN112457326B (zh) * | 2019-09-06 | 2022-02-15 | 上海凌达生物医药有限公司 | 一类芳香杂环并内酰胺类化合物、制备方法和用途 |
-
2021
- 2021-09-21 US US17/480,323 patent/US11685744B2/en active Active
- 2021-09-21 AU AU2021345423A patent/AU2021345423A1/en active Pending
- 2021-09-21 MX MX2023003264A patent/MX2023003264A/es unknown
- 2021-09-21 CN CN202180077972.9A patent/CN116583283B/zh active Active
- 2021-09-21 WO PCT/US2021/051226 patent/WO2022061273A1/en not_active Ceased
- 2021-09-21 IL IL301509A patent/IL301509B1/en unknown
- 2021-09-21 CA CA3196016A patent/CA3196016A1/en active Pending
- 2021-09-21 JP JP2023518280A patent/JP2023543433A/ja active Pending
- 2021-09-21 EP EP21790738.5A patent/EP4214213A1/en active Pending
- 2021-09-21 KR KR1020237013408A patent/KR20230123919A/ko active Pending
-
2023
- 2023-03-16 US US18/185,193 patent/US20230357265A1/en active Pending
- 2023-04-19 ZA ZA2023/04541A patent/ZA202304541B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023543433A5 (https=) | ||
| JP2024517693A5 (https=) | ||
| WO2022232332A1 (en) | 2-aminobenzothiazole compounds and methods of use thereof | |
| AU2011240808B2 (en) | 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of JAK kinases | |
| AU2018201557B2 (en) | Heteroaryl pyridone and aza-pyridone compounds as inhibitors of Btk activity | |
| AU2018201903B2 (en) | SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS | |
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| JP2021503004A5 (https=) | ||
| JP2024502433A5 (https=) | ||
| TW202321242A (zh) | 雜環化合物及使用方法 | |
| JP2022531801A5 (https=) | ||
| JP2021504380A5 (https=) | ||
| BR112021001292A2 (pt) | compostos heterobicíclicos para inibir a atividade de shp2 | |
| WO2025049746A1 (en) | Compositions comprising werner syndrome helicase inhibitors and methods of using the same | |
| JP2015522002A5 (https=) | ||
| AU2023220657A1 (en) | Pharmaceutical compound | |
| EP4514784A1 (en) | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease | |
| JP2025501767A (ja) | アリールスルホンアミド化合物 | |
| CA3250703A1 (en) | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease | |
| WO2026006796A1 (en) | Compositions comprising werner syndrome helicase inhibitors and methods of using the same | |
| AU2022249724A1 (en) | Pharmaceutical compound | |
| WO2025230878A1 (en) | Macrocyclic compounds as modulators of kras and uses thereof | |
| AU2015201991A1 (en) | 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of JAK kinases |